Sustained release ranolazine formulations

Details for Australian Patent Application No. 2001240092 (hide)

International Classifications

Event Publications

14 October 2004 Application Accepted

Published as AU-B-2001240092

2 December 2004 Corrigenda

Applications Accepted - Name Index Under the name CV Therapeutics, Inc., Application No. 2001240092, remove INID (31), and , insert INID (62) 61425/99.

10 February 2005 Standard Patent Sealed

2 October 2008 Offer to Surrender

CV Therapeutics, Inc. 3172 Porter Drive , Palo Alto CA 94304, the Patentee of Letters Patent 2001240092 dated 27.01.2005 for an invention titled ' Sustained release ranolazine formulations' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender is accepted must lodge a request to be heard within one month from the date of this journal.

27 November 2008 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.